Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 38351-38400 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06682195
Neoadjuvant Chemotherapy Combined With Toripalimab for TNBC (NEOTORCH-BREAST02)
PHASE2
Recruiting
35 participants
Started: Oct 9, 2024 · Completed: Oct 1, 2029
1 condition
1 sponsor
13 locations
NCT05984433
Auricular Acupuncture as Part of Multimodal Analgesia After Lower Leg Fracture
NA
Recruiting
140 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT06643416
Efficacy and Safety of Add-on Timolol for EGFR-TKI and ALK-TKI Induced Paronychia
PHASE3
Recruiting
40 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT06279442
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
N/A
Recruiting
150 participants
Started: Oct 9, 2024 · Completed: Aug 25, 2025
2 conditions
1 sponsor
10 locations
NCT06506019
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression
PHASE1
Recruiting
30 participants
Started: Oct 9, 2024 · Completed: Jan 1, 2027
1 condition
2 sponsors
1 location
NCT06583031
Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years
PHASE1
Active, not recruiting
385 participants
Started: Oct 9, 2024 · Completed: Sep 28, 2025
2 conditions
1 sponsor
6 locations
NCT06630286
Study to Compare an Oral Weekly Islatravir/Lenacapavir Regimen With Bictegravir/Emtricitabine/Tenofovir Alafenamide in Virologically Suppressed People With HIV-1
PHASE3
Active, not recruiting
609 participants
Started: Oct 9, 2024 · Completed: Aug 31, 2030
1 condition
1 sponsor
106 locations
NCT06590220
Establishment of Multiparametric Prediction Models for Moderate to SevereThyroid Associated Ophthalmopathy
N/A
Recruiting
150 participants
Started: Oct 9, 2024 · Completed: Sep 6, 2028
1 condition
1 sponsor
1 location
NCT06588920
Brain Activity, Cognitive Function, and Walking Ability in Parkinson's Disease
N/A
Recruiting
70 participants
Started: Oct 9, 2024 · Completed: Aug 31, 2027
2 conditions
1 sponsor
2 locations
NCT07057726
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of SSS39 Injection in Healthy Chinese Subjects
PHASE1
Enrolling by invitation
48 participants
Started: Oct 9, 2024 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT06659666
The COPD Optimiser
N/A
Enrolling by invitation
100 participants
Started: Oct 9, 2024 · Completed: Feb 28, 2025
1 condition
2 sponsors
2 locations
NCT06650566
Study of LM-299 in Subjects Advanced Malignant Tumors
PHASE1/PHASE2
Recruiting
108 participants
Started: Oct 9, 2024 · Completed: Jul 31, 2027
1 condition
1 sponsor
6 locations
NCT06476483
Feasibility and Acceptability of Implementing DIALOG+ in a Psychiatric Rehabilitation Unit
NA
Enrolling by invitation
12 participants
Started: Oct 9, 2024 · Completed: May 30, 2025
1 condition
2 sponsors
1 location
NCT06444880
Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
PHASE2
Recruiting
40 participants
Started: Oct 9, 2024 · Completed: Jul 31, 2028
1 condition
2 sponsors
1 location
NCT06593691
Examining the Effectiveness of Multiwave Locked System Laser Treatment in Chronic Low Back Pain
NA
Recruiting
110 participants
Started: Oct 9, 2024 · Completed: Aug 31, 2026
1 condition
1 sponsor
1 location
NCT06419179
Maintenance Durvalumab (MEDI4736) and Olaparib (AZD2281) After Standard 1st Line Treatment (Carboplatin/Cisplatin, Etoposide, Durvalumab) in HRD Positive Extensive Disease (ED) Small-cell Lung Cancer (SCLC)
PHASE2
Enrolling by invitation
29 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT06367075
A Trial of Cadonilimab With Adriamycin in Patients With Advanced Soft Tissue Sarcoma
PHASE2
Recruiting
53 participants
Started: Oct 9, 2024 · Completed: Mar 31, 2029
1 condition
7 sponsors
1 location
NCT06630741
Support and Personalized Care in Alternative Midwifery Birth Units Versus Traditional Units in France: Effects on the Psychological Health of Couples and on the Health of the Mother and Child at the Age of 2 Years.
N/A
Recruiting
748 participants
Started: Oct 9, 2024 · Completed: Jul 9, 2025
1 condition
1 sponsor
3 locations
NCT06877312
Longitudinal Study to Investigate Different Transcranial Electrical Stimulation
NA
Recruiting
200 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2033
1 condition
1 sponsor
1 location
NCT06361173
Spanish BMT4me Usability & Acceptability
N/A
Recruiting
30 participants
Started: Oct 9, 2024 · Completed: May 1, 2026
1 condition
2 sponsors
2 locations
NCT06786026
QL1706 Plus Chemotherapy +/- Bevacizumab in 1L Treatment of R/mTNBC
PHASE2
Recruiting
60 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2028
1 condition
1 sponsor
1 location
NCT06829940
Efficacy of Baduanjin Exercise in COVID-19 Contraction Patients With Idiopathic Chronic Fatigue
NA
Recruiting
40 participants
Started: Oct 9, 2024 · Completed: Mar 1, 2025
1 condition
1 sponsor
1 location
NCT06474728
Effects of an Emollient Containing Postbiotic Saccharomyces and Lactobacillus on Pediatric Atopic Dermatitis
NA
Recruiting
98 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT07098598
Pancreatic Cancer Diagnosis With FAPI-PET Imaging
PHASE2/PHASE3
Recruiting
100 participants
Started: Oct 9, 2024 · Completed: Oct 31, 2026
8 conditions
1 sponsor
1 location
NCT06510231
Inspiratory Muscle Training in HFpEF
NA
Recruiting
68 participants
Started: Oct 9, 2024 · Completed: Apr 30, 2028
1 condition
2 sponsors
1 location
NCT06632691
Virtual Reality Headset and Acceptability of Rectosigmoidoscopy in Ulcerative Colitis: a Randomised Controlled Trial
NA
Recruiting
100 participants
Started: Oct 9, 2024 · Completed: Apr 9, 2027
1 condition
1 sponsor
2 locations
NCT05996185
Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
PHASE2
Recruiting
22 participants
Started: Oct 9, 2024 · Completed: Nov 30, 2027
1 condition
2 sponsors
1 location
NCT06975332
Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression
NA
Recruiting
35 participants
Started: Oct 9, 2024 · Completed: Sep 30, 2027
4 conditions
1 sponsor
2 locations
NCT06598891
PAS Balance Training for Parkinson Disease (PD)
NA
Recruiting
60 participants
Started: Oct 9, 2024 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT06595043
Effects of Different Occlusion Angles of Disposable Tracheal Blocker on Right One-lung Ventilation
NA
Recruiting
96 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
3 locations
NCT06594211
Allogeneic Anti-BCMA/GPRC5D Bispecific CAR-NK Cells (ACT-001) in Patients With Relapsed or Refractorymultiple Myeloma
NA
Not yet recruiting
18 participants
Started: Oct 9, 2024 · Completed: Oct 9, 2028
1 condition
2 sponsors
1 location
NCT06014827
Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
PHASE2
Recruiting
32 participants
Started: Oct 9, 2024 · Completed: Jul 11, 2026
2 conditions
2 sponsors
2 locations
NCT06525636
A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia
PHASE1/PHASE2
Recruiting
24 participants
Started: Oct 9, 2024 · Completed: May 10, 2028
1 condition
2 sponsors
8 locations
NCT06361836
Study of Single Doses of SBT777101 in Subjects With Hidradenitis Suppurativa
PHASE1
Recruiting
24 participants
Started: Oct 9, 2024 · Completed: Nov 30, 2026
1 condition
1 sponsor
6 locations
NCT06632236
5G-EMERALD: Amivantamab in Malignant Brain Tumours
PHASE1
Recruiting
12 participants
Started: Oct 9, 2024 · Completed: Mar 5, 2027
4 conditions
7 sponsors
2 locations
NCT06222203
Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
N/A
Recruiting
225 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2035
2 conditions
1 sponsor
1 location
NCT05962463
Pulsed Radiofrequency Therapy vs Canal Adductor Blockade in Knee Osteoarthritis
N/A
Recruiting
128 participants
Started: Oct 9, 2024 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT06608212
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
N/A
Active, not recruiting
150,000 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06259409
Regenn® Therapy System Safety Study
PHASE1
Recruiting
30 participants
Started: Oct 9, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT06669585
Cannabis Observations on Brain Waves, Retrieval, and Attention: Experiment 3
N/A
Recruiting
64 participants
Started: Oct 9, 2024 · Completed: Jan 31, 2026
3 conditions
2 sponsors
1 location
NCT06423898
Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.
PHASE4
Recruiting
284 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2028
1 condition
2 sponsors
18 locations
NCT06901713
Smoking Cessation Program With CBT and Mindfulness Audio Support: A Randomized Controlled Trial
NA
Recruiting
2,000 participants
Started: Oct 9, 2024 · Completed: Nov 1, 2026
1 condition
1 sponsor
1 location
NCT06321484
Intraperitoneal Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cells in Recurrent Ovarian Cancer
PHASE1
Recruiting
18 participants
Started: Oct 9, 2024 · Completed: Oct 31, 2031
5 conditions
2 sponsors
2 locations
NCT06635174
Efficacy of 50% Oral Dextrose As Pain Relief in Newborns Before Bladder Catheterization
NA
Enrolling by invitation
90 participants
Started: Oct 9, 2024 · Completed: Mar 1, 2025
2 conditions
1 sponsor
1 location
NCT06626282
Fertility and Ovarian Reserve in Female Childhood Cancer Survivors
N/A
Recruiting
340 participants
Started: Oct 9, 2024 · Completed: Dec 31, 2028
8 conditions
2 sponsors
3 locations
NCT06501612
Pilot RCT Evaluating Clinical Outcomes of Using Undermyfork Mobile App With Dexcom G7
NA
Recruiting
90 participants
Started: Oct 9, 2024 · Completed: Sep 30, 2026
1 condition
1 sponsor
1 location
NCT06588257
Acceptability of the HPV Vaccine and Anal HPV in Transgender Women and Men Who Have Sex With Men: A Pilot Study
PHASE4
Active, not recruiting
101 participants
Started: Oct 9, 2024 · Completed: Apr 9, 2026
1 condition
2 sponsors
1 location
NCT06637462
A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer
NA
Recruiting
30 participants
Started: Oct 9, 2024 · Completed: Oct 9, 2027
2 conditions
1 sponsor
6 locations
NCT06470048
A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis
PHASE2
Recruiting
200 participants
Started: Oct 9, 2024 · Completed: Jul 15, 2030
1 condition
1 sponsor
103 locations
NCT06472414
A Women-Focused Cardiovascular Rehabilitation Program on Adherence, Health Related Physical Fitness, and Quality of Life
NA
Recruiting
82 participants
Started: Oct 8, 2024 · Completed: Apr 30, 2027
1 condition
2 sponsors
1 location
Previous
1
More pages
765
766
767
768
769
770
771
More pages
2369
Next